Eli Lilly Secures 70% Share of New Medicare GLP-1 Patients Following Coverage Launch
Eli Lilly Chief Executive Dave Ricks revealed that 700,000 seniors have started GLP-1 treatments since Medicare began covering anti-obesity medications in July, with Lilly therapies accounting for 70% of new patients.

